Joincare Pharmaceutical Earnings Estimate

600380 Stock   11.12  0.05  0.45%   
By analyzing Joincare Pharmaceutical's earnings estimates, investors can diagnose different trends across Joincare Pharmaceutical's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Joincare Pharmaceutical Group is based on EPS before non-recurring items and includes expenses related to employee stock options. Joincare Pharmaceutical is projected to generate 0.0 in earnings per share on the 31st of December 2019. Joincare Pharmaceutical earnings estimates module stress-tests analyst consensus about projected Joincare Pharmaceutical Group EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Many public companies, such as Joincare Pharmaceutical, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Joincare Pharmaceutical's earnings estimates, investors can diagnose different trends across Joincare Pharmaceutical's analyst sentiment over time as well as compare current estimates against different timeframes. As of November 26, 2024, Gross Profit is expected to decline to about 8.9 B
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Joincare Pharmaceutical Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Joincare Pharmaceutical Earnings per Share Projection vs Actual

About Joincare Pharmaceutical Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Joincare Pharmaceutical earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Joincare Pharmaceutical estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Joincare Pharmaceutical fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings9.4 B9.9 B

Currently Active Assets on Macroaxis

Other Information on Investing in Joincare Stock

Joincare Pharmaceutical financial ratios help investors to determine whether Joincare Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Joincare with respect to the benefits of owning Joincare Pharmaceutical security.